2 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
Follow Chronic Inflammatory Demyelinating Polyneuropathy: new trials by email Literature Review of Chronic Inflammatory Demyelinating Polyneuropathy trials Research Report on Chronic Inflammatory Demyelinating Polyneuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment KITE-363, Fludarabine, Cyclophosphamide - Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis | Phase 1 | Recruiting | Kite, A Gilead Company | 57 | 2026-04-10 | 2026-10-19 |
| IVIG vs SCIG in CIDP Intravenous immune globulin G, Subcutaneous immune globulin G - CIDP, Immunoglobulin Deficiency | Phase 1 | Recruiting | Rutgers, The State University of New Jersey | 20 | 2022-09-11 | 2025-12-11 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (2) · Agammaglobulinemia (1) · Multiple Sclerosis (1) · Myasthenia Gravis (1) · Obesity (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Chronic Disease (2) · Demyelinating Diseases (2) · Disease Attributes (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Peripheral Nervous System Diseases (2) · Polyneuropathies (2) · Polyradiculoneuropathy (2) · Blood Protein Disorders (1) · Body Weight (1)
Cyclophosphamide (1) · Hizentra (1) · Immunoglobulins, Intravenous (1) · fludarabine (1)
Kite, A Gilead Company (1) · Rutgers, The State University of New Jersey (1)
United States (2) · Australia (1) · Canada (1)